dm+d
108471007
Articles
Parkinson’s disease medicines in swallowing difficulties
13 June 2022Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties
Medicine Compliance Aid Stability
genericAccord Healthcare Ltd
Accord Healthcare Ltd
generic
Tablets 88 micrograms, 180 micrograms, 350 micrograms, 700 micrograms, 1.1mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in a MCA.
6 December 2022
MirapexinBoehringer Ingleheim
Boehringer Ingleheim
Mirapexin
Tablets 88 micrograms, 180 micrograms, 350 micrograms, 700 micrograms
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in a MCA
23 November 2022
Mirapexin Prolonged ReleaseBoehringer Ingelheim
Boehringer Ingelheim
Mirapexin Prolonged Release
Tablets m/r 260 micrograms, 520 micrograms, 1.05mg, 1.57mg, 2.1mg , 2.62mg, 3.15mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture. Max 14 days in a MCA.
23 November 2022
Lactation Safety Information
Levodopa, (as co-beneldopa or co-careldopa)
May interfere with lactation
No published evidence of safety
Dopamine receptor agonist
18 September 2020